KR970061867A - Glutamate derivatives, pharmaceutically acceptable salts thereof and anticonvulsants containing the active ingredients thereof - Google Patents
Glutamate derivatives, pharmaceutically acceptable salts thereof and anticonvulsants containing the active ingredients thereof Download PDFInfo
- Publication number
- KR970061867A KR970061867A KR1019960004377A KR19960004377A KR970061867A KR 970061867 A KR970061867 A KR 970061867A KR 1019960004377 A KR1019960004377 A KR 1019960004377A KR 19960004377 A KR19960004377 A KR 19960004377A KR 970061867 A KR970061867 A KR 970061867A
- Authority
- KR
- South Korea
- Prior art keywords
- pharmaceutically acceptable
- anticonvulsants
- acceptable salts
- active ingredients
- acceptable salt
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
본 발명은 글루탐산 유도체 및 약제학적으로 허용가능한 그의 염 및 이를 유효성분으로 하는 항경련제에 관한 것이다.The present invention relates to a glutamate derivative, a pharmaceutically acceptable salt thereof and an anti-convulsant agent containing the same as an active ingredient.
본 발명의 화합물은 기존의 항 경련성 화합물등의 공통된 구조를 하나의 분자내에 포함하고 있어 기존의 항 경련성 화합물보다 광범위한 항 경련활성을 나타낸다.The compound of the present invention contains a common structure such as a conventional anticonvulsant compound in one molecule and exhibits a broader anticonvulsant activity than conventional anticonvulsive compounds.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is a trivial issue, I did not include the contents of the text.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019960004377A KR970061867A (en) | 1996-02-23 | 1996-02-23 | Glutamate derivatives, pharmaceutically acceptable salts thereof and anticonvulsants containing the active ingredients thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019960004377A KR970061867A (en) | 1996-02-23 | 1996-02-23 | Glutamate derivatives, pharmaceutically acceptable salts thereof and anticonvulsants containing the active ingredients thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
KR970061867A true KR970061867A (en) | 1997-09-12 |
Family
ID=66222018
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019960004377A KR970061867A (en) | 1996-02-23 | 1996-02-23 | Glutamate derivatives, pharmaceutically acceptable salts thereof and anticonvulsants containing the active ingredients thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR970061867A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4558057A (en) * | 1981-12-15 | 1985-12-10 | Burzynski Stanislaw R | Purified antineoplaston fractions and methods of treating neoplastic disease |
EP0448972A2 (en) * | 1990-02-27 | 1991-10-02 | G.D. Searle & Co. | Process for preparation of 3-aryl-3-aminoalkyl-2,6-dioxohexahydropyridines |
US5112976A (en) * | 1985-11-01 | 1992-05-12 | National Research Development Corporation | Preparation of 2,6-dioxopiperidine derivatives |
-
1996
- 1996-02-23 KR KR1019960004377A patent/KR970061867A/en active IP Right Grant
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4558057A (en) * | 1981-12-15 | 1985-12-10 | Burzynski Stanislaw R | Purified antineoplaston fractions and methods of treating neoplastic disease |
US5112976A (en) * | 1985-11-01 | 1992-05-12 | National Research Development Corporation | Preparation of 2,6-dioxopiperidine derivatives |
EP0448972A2 (en) * | 1990-02-27 | 1991-10-02 | G.D. Searle & Co. | Process for preparation of 3-aryl-3-aminoalkyl-2,6-dioxohexahydropyridines |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR960034164A (en) | Stilbene derivatives and pharmaceutical compositions containing them | |
KR970705973A (en) | EXTERNAL SKIN PREPARATION | |
YU11997A (en) | Lactamic derivatives and pharmaceutical compositions thereof | |
KR930002325A (en) | Pyrimidine derivatives | |
BR0111639A (en) | Use of an oligodeoxynucleic acid molecule, and pharmaceutical composition containing it | |
KR950017957A (en) | Preparation and intermediates of 3, 4, 4-trisubstituted-piperidinyl-N-alkylcarboxylates | |
RS49907B (en) | Storable active substance concentrate with formoterol | |
DE69705300D1 (en) | CYCLOPROPYLALKANIC ACID DERIVATIVES | |
RS50046B (en) | PHARMACEUTICAL COMPOSITIONS OF TIZOXANIDE AND NITAZOXANIDE | |
ATE252369T1 (en) | PRESERVATION SYSTEMS FOR MEDICINAL PRODUCTS CONTAINING CYCLODEXTRINS | |
KR970707108A (en) | (DI-TERT-BUTYLPHENOL COMPOUNDS WITH HETEROCYCLIC MOIETY, USEFUL AS ANTI-INFLAMMATORY AGENTS) | |
EP0955046A3 (en) | Amino acid derivatives and anti-inflammatory agents | |
TR200000153T2 (en) | 6-azauracil derivatives that inhibit il-5. | |
KR960037677A (en) | 4-indolylpiperazinyl derivative | |
KR970061867A (en) | Glutamate derivatives, pharmaceutically acceptable salts thereof and anticonvulsants containing the active ingredients thereof | |
EA200000092A1 (en) | ANTIALLERGICAL MEANS | |
EA200100956A1 (en) | PHARMACEUTICAL COMPOSITIONS BASED ON TIZOXANIDE AND NITAZOXANIDE | |
DE69330601D1 (en) | SEROTON INERGIC ERGOLIN DERIVATIVES | |
DE69825977D1 (en) | ANTIVIRAL AGENTS | |
KR970061248A (en) | 1, 1, 2-triphenylbut-1-ene derivative for the treatment of Alzheimer's disease | |
KR900701762A (en) | Tetrahydropyrimidine derivatives | |
NO964801D0 (en) | explosive Mixtures | |
HUP0004362A2 (en) | Parenteral formulations comprising carbamazepine or its derivatives | |
KR980002033A (en) | Triazole derivatives or salts thereof | |
KR960703595A (en) | ANTIDEPRESSANT |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
NORF | Unpaid initial registration fee |